Muscle-derived stem cells: Characterization and potential for cell-mediated therapy

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 5, 2001, Pages 924-933

  Deasy, Bridget M ^a   Jankowski, Ron J ^a   Huard, Johnny ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL FATE; CELL ISOLATION; CELL LINEAGE; EMBRYO DEVELOPMENT; GENE THERAPY; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; PHENOTYPE; PRIORITY JOURNAL; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL; ANIMAL; CYTOLOGY; METHODOLOGY; REVIEW; STEM CELL TRANSPLANTATION;

ANIMAL; CELL LINEAGE; HUMAN; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; STEM CELL TRANSPLANTATION; STEM CELLS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035214033     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0463     Document Type: Article

References (62)

1. Satellite cells of skeletal muscle fibers
2. Developmental fate of skeletal muscle satellite cells
3. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells
4. The satellite cell and muscle regeneration
5. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers
6. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells
7. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells
8. Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf5 generates 'reserve cells'
9. Seeking muscle stem cells
10. A new look at the origin, function, and "stem-cell" status of muscle satellite cells
11. Isolation and differentiation of mesenchymal stem cells from rabbit muscle
12. Pluripotent mesenchymal stem cells reside within avian connective tissue matrices
13. Isolation of embryonic chick myosatellite and pluripotent stem cells
14. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes
15. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-I
16. Multilineage potential of adult human mesenchymal stem cells
17. Bone morphogenic protein-2 converts differentiation pathway of C2C12 myoblasts into the osteoblast lineage
18. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
19. Osteoprogenitor cells within skeletal muscle
20. Ex vivo gene therapy to produce bone using different cell types
21. Dystrophin expression in the mdx mouse restored by stem cell transplantation
22. Hematopoietic potential of stem cells isolated from murine skeletal muscle
23. Pax7 is required for the specification of myogenic satellite cells
24. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell
25. The flt3/flk-2 ligand: Receptor distribution and action on murine haemopoietic cell survival and proliferation
26. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells
27. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells
28. Isolation of two populations of myoblasts from porcine skeletal muscle
29. Clonal analysis of hematopoietic stem-cell differentiation in vivo
30. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
31. Bone marrow as a potential source of hepatic oval cells
32. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation
33. Muscle regeneration by bone marrow-derived myogenic progenitors
34. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice
35. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow
36. Development of approaches to improve cell survival in myoblast transfer therapy
37. Intra-arterial injection of muscle-derived CD34+Sca-1 + stem cells restores dystrophin in mdx mice
38. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: Potential for rapid isolation of muscle-derived stem cells
39. Introduction: Focus on hematology CD34(+) or CD34(-): Does it really matter?
40. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
41. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell
42. Functional activity of murine CD34+ and CD34- hematopoietic stem cell populations
43. Reversible expression of CD34 by murine hematopoietic stem cells
44. Skeletal myogenic progenitors originating from embryonic dorsal aorta co-express endothelial and myogenic markers and contribute to post-natal muscle growth and regeneration
45. Myogenic stem cells for the therapy of primary myopathies: Wishful thinking or therapeutic perspective?
46. Ex vivo expansion of hematopoietic precursor cells
47. A potential molecular approach to ex vivo hematopoietic expansion with recombinant epidermal growth factor receptor-expressing adenovirus vector
48. Ex vivo expansion of hematopoietic stem and progenitor cells: Are we there yet?
49. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34(+)Thy1(+)lin- cells
50. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells
51. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro
52. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor
53. Insulin-like growth factor (IGF)-binding protein-related protein-1: An autocrine/ paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF
54. Mechanisms of muscle stem cell expansion with cytokines
55. Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts
56. Quantitative studies of efficacy of myoblast transplantation
57. Gene transfer into skeletal muscles by isogenic myoblasts
58. Rapid death of injected myoblasts in myoblast transfer therapy
59. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
60. Control of inflammatory damage by anti-LFA-1: Increased success of myoblast transplantation
61. Problems and solutions in myoblast transfer therapy